| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $212.0M | -6.8% |
| Cost of Revenue | $7.6M | +11.9% |
| R&D Expense | $7.5M | -96.4% |
| SG&A Expense | $220.2M | +46.9% |
| Operating Income | -$266.6M | -64.8% |
| Interest Expense | $11.3M | -43.8% |
| Pre-tax Income | -$278.2M | -54.8% |
| Income Tax | $313K | -23.5% |
| Net Income | -$278.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.7M | -62.8% |
| Accounts Receivable | $16.6M | +4.6% |
| Inventory | $6.9M | -5.3% |
| Current Assets | $486.4M | -16.5% |
| Total Assets | $672.6M | -13.4% |
| Current Liabilities | $142.2M | +14.6% |
| Total Liabilities | $629.7M | +32.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$186.3M | -1159.4% |
| Capital Expenditures | $191K | -96.3% |
| Investing Cash Flow | -$32.6M | +76.3% |
| Financing Cash Flow | $117.6M | -49.3% |
| Free Cash Flow | -$186.5M | -837.4% |
| -54.6% |
| EPS (Basic) | -$4.37 | -45.2% |
| EPS (Diluted) | -$4.37 | -45.2% |
| Stockholders' Equity |
| $42.9M |
| -85.8% |